Latest Biosimilar Stories
LONDON, April 25, 2014 /PRNewswire/ -- Turkey, with its ambitious social and economic roadmap, is regarded as a rising star in the region.
New Entity YL Biologics to focus on clinical development and commercialization of Biosimilars for Japan MUMBAI and BALTIMORE, April 23, 2014 /PRNewswire/ -- Pharma
Brazilian Public-Private Partnerships Drive Strong Growth in Biosimilars Pipeline, According to Findings from Decision Resources Group BURLINGTON, Mass., April 22, 2014 /PRNewswire/ -- Decision
DUBLIN, April 15, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Mylan Inc. and Famy Care Ltd.
Transparency Market Research Report Added "Biosimilar And Follow-On Biologics Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018" to its database.
Transparency Market Research Report added "Global Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database.
Transparency Market Research Report Added "Biosimilars Market - Global And China Forecast, Share, Size, Growth And Industry Analysis 2010 - 2017" to its database.
New research report “Biosimilar Index: Tracking the Global Biosimilar Pipeline” worked out by FirstWord is now available at MarketPublishers.com London,
Three-Arm Phase I Trials are Being Used to Streamline Biosimilar Development, According to Findings from Decision Resources Group BURLINGTON, Mass., April 8, 2014 /PRNewswire/ -- Decision Resources
Development to Employ Catalent’s Leading GPEx® Cell Line Technology for Chinese Market Somerset, N.J.
- A transitional zone between two communities containing the characteristic species of each.